<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="50363">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02023229</url>
  </required_header>
  <id_info>
    <org_study_id>Enterex01</org_study_id>
    <nct_id>NCT02023229</nct_id>
  </id_info>
  <brief_title>Branched Chain Aminoacid Supplementation in Patients With Liver Cirrhosis</brief_title>
  <official_title>High-fiber High-fiber Diet and Branched Chain Aminoacids. Impact on Nutritional Status and Complications in Patients With Liver Cirrhosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</source>
  <oversight_info>
    <authority>Mexico: Secretaria de Salud</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Malnutrition is a frequent complication in patients with liver cirrhosis. Most patients have
      decreased dietary intake due to ascites, hepatic encephalopathy and pro-inflammatory
      cytokines.

      We hypothesized that branched chain aminoacids can improve nutritional status and delay
      episodes of hepatic encephalopathy
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">May 2013</completion_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Nutritional status</measure>
    <time_frame>At time of recruitment</time_frame>
    <safety_issue>No</safety_issue>
    <description>Assessed by bioelectrical impedance vector analysis and mid-arm muscle circumference</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hepatic Encephalopathy</measure>
    <time_frame>At time of recruitment</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Nutritional status</measure>
    <time_frame>3 months follow-up</time_frame>
    <safety_issue>No</safety_issue>
    <description>Assessed by bioelectrical impedance vector analysis and mid-arm muscle circumference</description>
  </other_outcome>
  <other_outcome>
    <measure>Nutritional status</measure>
    <time_frame>6 months follow-up</time_frame>
    <safety_issue>No</safety_issue>
    <description>Assessed by bioelectrical impedance vector analysis and mid-arm muscle circumference</description>
  </other_outcome>
  <other_outcome>
    <measure>Hepatic encephalopathy</measure>
    <time_frame>6 months follow-up</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">68</enrollment>
  <condition>Liver Cirrhosis</condition>
  <arm_group>
    <arm_group_label>Diet plus branched chain aminoacids</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High-fiber high-protein diet Oral supplement : branched chain aminoacids</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>High-fiber high-protein diet</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Branched-chain aminoacids</intervention_name>
    <arm_group_label>Diet plus branched chain aminoacids</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High-fiber high protein diet</intervention_name>
    <arm_group_label>Diet plus branched chain aminoacids</arm_group_label>
    <arm_group_label>Diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Ambulatory patients Patients with confirmed diagnose of liver cirrhosis Patients
        classified as Child-Pugh A or Child Pugh B

        Exclusion Criteria:

        Acute or chronic renal failure Pregnancy Overt hepatic encephalopathy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Instituto Nacional de Ciencias Médicas y Nutrición &quot;Salvador Zubirán&quot;</name>
      <address>
        <city>Mexico city</city>
        <zip>14000</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 23, 2013</lastchanged_date>
  <firstreceived_date>December 23, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</investigator_affiliation>
    <investigator_full_name>ALDO TORRE DELGADILLO</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>Branched chain aminoacids</keyword>
  <keyword>Nutritional status</keyword>
  <keyword>Hepatic encephalopathy</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
